BDNF could potentially serve as a valuable biomarker for treatment, particularly in cases of MDD, as elevated levels are observed in individuals responding positively to therapeutic interventions, while non-responders exhibit no such alteration [23]. This evidence concerns the gene BDNF and major depressive disorder.